Vaginal Cancer Surgery

Introduction

A diagnosis of vaginal cancer can feel isolating. Because this cancer is rare, clear information about treatment can be harder to find than for more common gynecologic cancers. You may already have questions about what surgery will involve, how it will affect urinary and sexual function, whether radiation or chemotherapy will also be needed, and what recovery looks like over the months ahead.

This guide is written for someone who has been diagnosed with primary vaginal cancer or a recurrence, and is now planning treatment. It explains what vaginal cancer surgery involves, the different surgical approaches doctors use depending on the tumour, how surgery fits with radiation and chemotherapy, what to expect during recovery, and the longer-term considerations that follow.

Vaginal cancer is uncommon, and the right plan for any one patient depends on tumour stage, location, prior radiation exposure, overall health, and personal priorities. Surgical decisions are best made with a gynecologic oncology team that sees these cancers regularly.

What Is Vaginal Cancer Surgery?

Vaginal cancer surgery is the removal of cancerous tissue from the vagina, sometimes along with nearby lymph nodes or surrounding structures. The goal is to take out all of the cancer with a rim of healthy tissue around it — what surgeons call “clear margins” — while preserving urinary, bowel, and sexual function as much as the cancer allows.

Primary vaginal cancer means cancer that started in the vagina itself, not cancer that spread from the cervix, vulva, uterus, or another organ. The most common type is squamous cell carcinoma, which arises from the cells lining the vaginal wall. Less common types include adenocarcinoma, melanoma, and sarcoma. The type of cancer influences which treatments doctors consider.

Because vaginal cancer is rare, many general gynecologists may see only a handful of cases in their career. Major societies, including the National Comprehensive Cancer Network (NCCN) and the European Society of Gynaecological Oncology (ESGO), recommend that treatment be planned and delivered by specialised gynecologic oncology teams working with radiation oncologists and pathologists. This kind of multidisciplinary review — sometimes called a tumour board — is now standard in cancer centres.

Surgery is one of three main treatment modalities for vaginal cancer. The others are radiation therapy (often combined with chemotherapy, called chemoradiation) and chemotherapy. For many patients, especially those with more advanced disease, radiation-based treatment rather than surgery is the primary approach. Surgery has a clearer role for selected early-stage tumours, certain recurrences, and a small group of patients where surgery offers the best chance of cure or function preservation.

Why Is Vaginal Cancer Surgery Performed?

Surgery is considered in vaginal cancer for several distinct reasons. Understanding which applies to your situation helps clarify what the operation is meant to achieve.

To remove early-stage tumours

For small, well-defined Stage I tumours in the upper vagina, surgery can sometimes remove the cancer completely without the need for radiation. Avoiding radiation, when safely possible, can help preserve vaginal tissue, reduce long-term scarring, and protect fertility in younger patients.

To treat selected Stage II disease

Some Stage II cancers — where tumour has spread slightly beyond the vaginal wall but is still localised — may be treated surgically, often combined with radiation or chemoradiation depending on the final pathology.

To treat recurrent cancer after radiation

If cancer comes back in the pelvis after a course of radiation, further radiation often cannot be safely given. In carefully selected patients, surgery becomes the main option for cure. These operations are larger, but they can offer long-term disease control when no other curative path is available.

To treat high-grade precancerous changes (VAIN)

Vaginal intraepithelial neoplasia (VAIN) is a precancerous condition of the cells lining the vagina. High-grade VAIN that does not respond to other treatments — such as topical therapy or laser ablation — may be removed surgically to prevent progression to invasive cancer.

To relieve symptoms in advanced disease

Occasionally surgery is used not to cure cancer but to relieve symptoms such as bleeding, fistula formation, or obstruction. This is called palliative surgery and is reserved for situations where the benefit clearly outweighs the burden of the operation.

Who Is a Candidate?

Several factors influence whether surgery is the right primary treatment for any particular patient with vaginal cancer.

Tumour stage and size. Early-stage, small tumours are more likely to be treated surgically. Larger tumours, those that invade adjacent organs, or those with significant lymph node involvement are more often treated with radiation-based approaches.

Tumour location. Cancers in the upper third of the vagina are sometimes amenable to surgery that resembles a radical hysterectomy. Cancers in the lower vagina sit closer to the urethra and anus, and surgery here can be more disruptive to function — so radiation is often preferred. Mid-vagina tumours fall in between, and the decision depends on individual anatomy.

Prior treatment. Patients who have already had pelvic radiation for another cancer have limited capacity to receive more radiation. In this group, surgery may move higher on the list of options for a new vaginal cancer or a recurrence.

General health. Major pelvic surgery requires the ability to tolerate general anaesthesia and a significant recovery. Heart, lung, and kidney function are evaluated carefully. Some patients with substantial coexisting illness may be safer with non-surgical treatment.

Patient priorities. Sexual function, body image, urinary and bowel control, and fertility (in pre-menopausal patients) all factor into the decision. These are not afterthoughts — they are central to choosing between options that may offer similar cancer outcomes by different routes.

A gynecologic oncology team will explain whether surgery, radiation, or a combination is the best fit for your specific cancer and circumstances.

Alternatives to Surgery

Surgery is one of several treatments for vaginal cancer. For many patients, especially those with locally advanced disease, the main treatment is not surgery at all. Understanding the alternatives helps put the surgical decision in context.

Radiation therapy

Radiation is the most common primary treatment for vaginal cancer overall. It can be delivered in two ways, often combined:

• External beam radiation therapy (EBRT) directs high-energy radiation at the tumour and surrounding pelvic tissues from a machine outside the body. Modern techniques such as intensity-modulated radiation therapy (IMRT) shape the dose to spare normal tissues.
• Brachytherapy places a radiation source inside or right next to the tumour using a small applicator in the vagina. This delivers a high dose directly to the cancer while reducing dose to nearby organs.

For Stage II and more advanced disease, radiation is typically the backbone of treatment, often combined with chemotherapy to make it more effective.

Chemoradiation

Combining chemotherapy with radiation — called chemoradiation — is the standard approach for many Stage II to IVA vaginal cancers. The chemotherapy makes cancer cells more sensitive to radiation. Cisplatin given weekly during the radiation course is the most common regimen, based on experience extrapolated from cervical cancer treatment, where the evidence is stronger.

Chemotherapy alone

For very advanced or metastatic disease, chemotherapy may be the main treatment. Newer treatments, including immunotherapy, are also being studied for selected vaginal cancers, particularly those with specific molecular features.

Topical or local treatments for VAIN

For precancerous VAIN, alternatives to surgery include topical agents such as imiquimod or 5-fluorouracil cream, and laser ablation. These can preserve more vaginal tissue but require close follow-up to confirm the abnormal cells have cleared.

Active monitoring

For low-grade VAIN, careful observation with repeated examinations may be appropriate. This is decided on a case-by-case basis with a gynecologic oncology team.

The choice between surgery and non-surgical treatment is rarely a simple either/or. Many treatment plans combine modalities, with surgery and radiation each playing a specific role.

Surgical Approaches

Several different operations fall under the umbrella of vaginal cancer surgery. The choice depends on the tumour’s size, location, depth of invasion, and whether lymph nodes are involved.

Local (wide local) excision

For small, superficial early-stage tumours, surgeons may remove only the tumour and a rim of normal tissue around it. The aim is clear margins with minimal disruption to the vaginal wall. This is the least extensive option and is generally used for very early-stage cancers or for high-grade VAIN that has not responded to other treatments.

Partial vaginectomy

Partial vaginectomy removes part of the vaginal wall containing the tumour, along with surrounding healthy tissue. Depending on how much wall is removed and where, this may shorten the vagina or change its calibre. In many cases the remaining vagina heals and continues to function, sometimes with the help of vaginal dilators or, less commonly, reconstruction.

Radical vaginectomy

Radical vaginectomy involves removing most or all of the vagina along with the supporting connective tissue. When the tumour sits in the upper vagina, this operation often extends to remove the uterus and cervix as well — combining vaginectomy with radical hysterectomy. Pelvic lymph nodes are typically removed at the same time. Reconstruction of the vagina may be considered, depending on the patient’s wishes and the surgeon’s recommendations.

Pelvic exenteration

Pelvic exenteration is the most extensive operation in the pelvis. It removes the vagina along with one or more adjacent organs — the bladder, the rectum, or both — when cancer has invaded them, or when previous radiation has not controlled disease and no other curative option exists. Removing the bladder requires creating a new way to drain urine (a urostomy or continent reservoir). Removing the rectum requires a colostomy. Vaginal reconstruction is often part of the same operation.

This is a major procedure with significant recovery, and it is reserved for carefully selected patients in whom it offers a realistic chance of cure. Decisions about exenteration are made in specialist centres after detailed imaging and counselling.

Lymph node removal (lymphadenectomy)

Vaginal cancer can spread to nearby lymph nodes. Which nodes are most at risk depends on the tumour’s location:

• Upper vagina: pelvic lymph nodes
• Lower vagina: inguinal (groin) lymph nodes
• Mid-vagina: either or both

Pelvic or inguinal lymphadenectomy may be performed at the time of vaginectomy, or sentinel lymph node biopsy — removing only the first node or nodes that cancer would drain to — may be used in selected cases to reduce side effects such as lymphedema. Sentinel node techniques are more established in vulvar and cervical cancer; their role in vaginal cancer is evolving.

Open versus minimally invasive surgery

Vaginal cancer operations can be performed through different access routes:

• Open surgery uses a single larger incision in the abdomen. It remains the standard for extensive disease and complex reconstructions.
• Laparoscopic surgery uses several small incisions and a camera. It can reduce hospital stay and pain in selected cases.
• Robotic-assisted surgery is a form of laparoscopic surgery using a robotic platform that gives the surgeon precise instrument control.

The minimally invasive approaches are not appropriate for every vaginal cancer operation. Decisions about access are based on tumour characteristics, the planned extent of resection, the surgeon’s experience, and the equipment available. For advanced cancers, open surgery is often the safer choice.

Vaginal reconstruction

When a large portion of the vagina is removed, reconstruction may be offered. Techniques include using flaps of skin and muscle from the thigh, abdomen, or buttock to create a new vaginal canal. Reconstruction is not always possible or chosen, and it adds to operating time and recovery. The decision is personal and should be discussed before surgery, with realistic expectations of how a reconstructed vagina will look, feel, and function.

Preparing for Surgery

Once surgery is planned, you will go through a structured pre-operative evaluation. This serves two purposes: confirming the operation is the right choice, and making sure your body is ready for it.

Confirming the diagnosis and stage

If not already complete, the workup typically includes:

• Pelvic examination, often under anaesthesia for accurate assessment
• Biopsy confirming the cancer type
• MRI of the pelvis to show the tumour’s depth and relationship to surrounding organs
• CT scan or PET-CT to look for spread beyond the pelvis
• Cystoscopy (looking inside the bladder) if the tumour is near the bladder
• Proctoscopy or sigmoidoscopy if the tumour is near the rectum
• Blood tests to assess overall health and organ function

This information allows the surgical team to plan the specific operation, including whether lymph nodes will be removed and whether reconstruction will be needed.

Multidisciplinary review

Major societies recommend that vaginal cancer cases be discussed at a multidisciplinary tumour board — a meeting of gynecologic oncologists, radiation oncologists, medical oncologists, pathologists, and radiologists. This review confirms the stage and ensures the treatment plan reflects current best practice.

Medical optimisation

Before surgery you may be asked to:

• Stop smoking, ideally several weeks before the operation, to improve healing
• Optimise control of conditions such as diabetes, high blood pressure, or anaemia
• Adjust certain medications, particularly blood thinners, on the surgeon’s instructions
• Improve nutrition if you have lost weight or have low protein levels
• Begin gentle physical activity to build stamina before surgery (sometimes called “prehabilitation”)

Discussing function and fertility

Before surgery is the right time to have honest conversations about:

• Expected effects on sexual function and what reconstruction options exist
• Bladder and bowel function, particularly if exenteration is planned
• Fertility preservation if you are pre-menopausal and may want children — egg or embryo freezing may be possible before treatment
• Emotional support, including counselling, before and after surgery

Writing your questions down before each appointment helps make sure nothing important is missed.

What Happens During Surgery

On the day of surgery, you will be admitted to the hospital, change into a gown, and meet members of the surgical team. An anaesthesiologist will discuss the plan for general anaesthesia, which means you will be fully asleep and feel nothing during the operation.

The exact steps depend on which operation is planned. In general:

1. You are placed in a position that gives the surgeon access to the vagina, abdomen, or both, depending on the approach.
2. The skin and surgical field are cleaned and draped.
3. The surgeon performs the planned resection — local excision, partial or radical vaginectomy, or exenteration — with the goal of clear margins around the tumour.
4. Lymph nodes are removed if planned.
5. If reconstruction is planned, the surgeon constructs a new vaginal canal using tissue from another part of the body.
6. If the bladder or rectum has been removed, the urinary or bowel diversion is created.
7. Drains may be placed to remove fluid that accumulates after surgery.
8. Incisions are closed and dressings applied.

Operating time varies widely — from about an hour for a small local excision to many hours for pelvic exenteration with reconstruction. The tissue that is removed is sent to a pathologist, who examines it in detail over the following days. Final pathology guides whether any additional treatment is needed.

Recovery and Healing

Hospital stay

Approximate length of stay by operation type:

• Local excision: 1–2 days
• Partial vaginectomy: 3–5 days
• Radical vaginectomy: 5–10 days
• Pelvic exenteration: typically 10–14 days or longer, sometimes with time in a high-dependency unit

During the hospital stay, the team focuses on pain management, monitoring for bleeding and infection, managing urinary catheters or drains, and getting you up and walking as soon as safely possible. Early movement reduces the risk of blood clots and lung complications.

The first few weeks at home

After discharge, most patients experience:

• Pelvic discomfort and fatigue that improve gradually
• Some vaginal discharge or light bleeding as tissue heals
• Restrictions on lifting, driving, and strenuous activity
• A temporary urinary catheter in some cases
• Care of any stomas (urostomy or colostomy) if exenteration was performed, with support from a stoma nurse

Wound care instructions, signs of infection to watch for, and when to call the team will be explained before you leave hospital.

Weeks three to six

Most patients begin to feel substantially better during this period. Light activity is usually resumed. The first post-operative follow-up visit typically falls in this window, and the surgeon reviews the final pathology, discusses whether additional treatment is recommended, and examines the healing tissue.

Two to three months and beyond

By this point most patients return to many normal activities. Sexual activity is generally not resumed until the surgeon confirms healing is complete. If the vagina has been shortened or narrowed, vaginal dilators may be recommended to keep tissue pliable. Pelvic floor physiotherapy can help with bladder control, pelvic pain, and sexual rehabilitation.

For patients who had pelvic exenteration, recovery is longer — often six months or more — and includes learning to live with a stoma and any reconstructed structures.

Emotional recovery

Recovery is not only physical. Many patients experience grief about changes to the body, anxiety about recurrence, and shifts in how they feel about intimacy. These reactions are common and treatable. Talking with an oncology counsellor, joining a support group, or working with a sex therapist who has experience in cancer survivorship can make a significant difference. Asking for this support early, rather than waiting until distress is severe, generally leads to better outcomes.

Risks and Complications

Every operation carries risks. For vaginal cancer surgery, these can be grouped into general surgical risks and risks specific to operations in the pelvis.

General risks

• Bleeding during or after surgery
• Infection of the wound, urinary tract, or deeper tissues
• Blood clots in the legs or lungs (deep vein thrombosis and pulmonary embolism)
• Reactions to anaesthesia
• Slow wound healing

Pelvic-specific risks

• Injury to the bladder, ureters (the tubes from the kidneys to the bladder), or rectum
• Fistula — an abnormal connection between the vagina and the bladder or rectum that causes leakage
• Urinary problems including difficulty emptying the bladder, incontinence, or recurrent infections
• Bowel changes, including constipation or, after exenteration, learning to manage a colostomy
• Sexual dysfunction, including pain with intercourse, reduced lubrication, and changes to vaginal length or shape
• Vaginal shortening or narrowing
• Lymphedema — swelling of the legs or genital area — when pelvic or inguinal lymph nodes are removed
• Numbness in the upper inner thigh after inguinal lymph node removal

The likelihood of each complication varies with the operation. Local excision carries low risk; pelvic exenteration carries much higher risk. Complication rates are lower when these operations are performed by experienced gynecologic oncology teams in centres that handle them regularly.

Adjuvant Treatment After Surgery

After surgery, the removed tissue is examined by a pathologist. The report describes the tumour type, size, depth of invasion, margin status (whether cancer cells reach the edge of removed tissue), and lymph node involvement. This pathology guides whether further treatment — called adjuvant treatment — is recommended.

Adjuvant radiation

Doctors may recommend post-operative radiation when:

• Margins are positive or very close
• Lymph nodes contain cancer
• The tumour shows aggressive features on pathology

Adjuvant chemoradiation

Combining chemotherapy with radiation may be considered when there are higher-risk features, such as multiple positive nodes or extensive disease. Cisplatin is the most common chemotherapy drug used in this setting.

Chemotherapy alone

Chemotherapy without radiation is occasionally used when there is concern about disease that has spread beyond what radiation can cover.

Decisions about adjuvant treatment are made by the multidisciplinary team after reviewing the final pathology. The aim is to reduce the risk of recurrence while keeping side effects manageable.

Life After Vaginal Cancer Surgery

Life after treatment unfolds over years rather than weeks. Three areas usually need ongoing attention: surveillance for recurrence, managing long-term effects, and emotional and relational adjustment.

Follow-up and surveillance

Most vaginal cancer recurrences happen within the first two to three years after treatment. Major society guidelines, including those from NCCN and ESGO, recommend close follow-up during this period, usually with:

• Clinic visits every three to six months for the first two to three years
• Less frequent visits (every six to twelve months) for the next two to three years
• Annual visits thereafter
• Pelvic examinations at each visit
• Pap or vaginal cytology in selected cases
• Imaging (CT, MRI, or PET-CT) when symptoms or examination raise concern

Symptoms to report between visits include new vaginal bleeding or discharge, pelvic pain, leg swelling, unexplained weight loss, or persistent urinary or bowel changes.

Sexual health and intimacy

Surgery can change vaginal length, sensation, lubrication, and the experience of intercourse. Radiation, if given, adds further changes including tissue dryness and reduced elasticity. Doctors typically recommend:

• Use of vaginal dilators to maintain or restore vaginal length and pliability
• Vaginal moisturisers and lubricants
• Local estrogen therapy in some cases (used cautiously after hormone-sensitive cancers)
• Pelvic floor physiotherapy
• Open communication with a partner
• Counselling with a sex therapist who works with cancer survivors

Bladder, bowel, and lymphedema care

If lymph nodes were removed, the risk of lymphedema in the legs or genital area persists for years. Early signs include swelling, heaviness, or tightness. Specialist lymphedema therapists can teach skin care, compression garment use, and decongestive therapy that significantly improve symptoms when started early.

Urinary and bowel changes — including after stoma formation — usually improve with time, specialist nursing support, and pelvic floor rehabilitation.

Emotional health and survivorship

Long after the wounds heal, the experience of having had cancer continues to shape daily life. Fear of recurrence is common, especially around scan time. Mood changes, anxiety, and relationship strain are common too. Many cancer centres now offer survivorship clinics that help with the transition from active treatment to long-term living with a cancer history. Mental health support — whether through counselling, peer support, or medication when needed — is part of comprehensive cancer care.

Outcomes and Prognosis

Outcomes after vaginal cancer surgery depend strongly on stage at diagnosis, tumour type, margin status, lymph node involvement, and response to any additional treatment. Because vaginal cancer is rare, outcome data come from smaller studies than for more common cancers, and individual results vary widely.

In broad terms:

• Early-stage, localised disease has the most favourable outlook, with many patients achieving long-term disease control after surgery, radiation, or both.
• Outcomes decline progressively with higher stage at diagnosis, particularly when lymph nodes are involved or when there is spread to nearby organs.
• Recurrent disease has more variable outcomes and depends heavily on the location of recurrence and whether further curative treatment is possible.

Personal prognosis is best discussed with the treating gynecologic oncologist, who can interpret your specific stage, pathology, and overall health rather than relying on broad averages. Survival statistics published in older studies do not necessarily reflect outcomes with modern surgical and radiation techniques.

Frequently Asked Questions

How is the choice between surgery and radiation made?

The decision depends on tumour stage and location, prior radiation history, general health, and personal priorities such as sexual function and fertility. For small, upper vaginal tumours, surgery may offer a way to avoid radiation. For larger or more centrally located tumours, radiation — often combined with chemotherapy — is usually the primary treatment. A gynecologic oncology team weighs these factors with you.

Will I still be able to have sex after surgery?

Many women do resume sexual activity after vaginal cancer surgery, sometimes with adaptation. The effect depends on how much of the vagina was removed and whether reconstruction was performed. Vaginal dilators, lubricants, pelvic floor therapy, and counselling all play a role. Talking honestly with your team before and after surgery helps set realistic expectations.

Can the vagina be reconstructed?

Yes, in selected cases. Reconstruction uses tissue from elsewhere in the body to create a new vaginal canal. It is most often considered after radical vaginectomy or pelvic exenteration. Reconstruction adds to operating time and recovery, and a reconstructed vagina functions and feels differently from a native one. It is not the right choice for every patient and should be discussed in detail before surgery.

Will I need a colostomy or urostomy?

Most vaginal cancer operations do not require stoma formation. A urostomy or colostomy is usually only needed when pelvic exenteration is performed, which involves removing the bladder, the rectum, or both. In that situation, the stoma nurse and surgical team prepare you in detail before surgery.

What is the chance the cancer will come back?

Recurrence risk depends on stage, tumour type, margin status, lymph node involvement, and whether additional treatment was given. Most recurrences happen within the first two to three years, which is why follow-up is most frequent during that period. Your treating team can give you the best personalised estimate.

Will I need radiation or chemotherapy after surgery?

Not always. For some early-stage cancers with clear margins and no lymph node involvement, surgery alone may be sufficient. For higher-risk pathology features, doctors typically recommend adjuvant radiation or chemoradiation to reduce the chance of recurrence. The decision is based on the final pathology report after surgery.

Can fertility be preserved?

This depends on the planned operation and any additional treatment. For some early-stage cancers in younger patients, fertility-sparing options may be considered. Egg or embryo freezing before treatment can be discussed with a fertility specialist. It is best to raise this question early, before treatment begins.

How long before I can return to normal activities?

Most patients return to light daily activities within four to six weeks after smaller operations and within two to three months after larger ones. Strenuous activity, lifting, and sexual activity typically resume later, on the surgeon’s advice. Recovery after pelvic exenteration is longer.

Conclusion

Vaginal cancer is rare, and the right treatment plan depends on details that are unique to each patient — the type of cancer, the stage, the location of the tumour, prior treatments, overall health, and what matters most to you about life after treatment. Surgery has an important role for selected early-stage tumours, certain recurrences, and high-grade precancerous changes, but it is one piece of a multimodal landscape that also includes radiation and chemotherapy.

Because of how uncommon vaginal cancer is, planning and care by an experienced gynecologic oncology team makes a meaningful difference to both cancer outcomes and quality of life afterwards. The conversations that matter most — about which operation, whether to add radiation, how to protect sexual and urinary function, and how to manage the emotional weight of the diagnosis — are best had with that team, with time to ask questions and consider the answers.

Vaginal cancer surgery is rarely simple, but for many patients it is part of a path that leads to long-term disease control and a meaningful return to daily life.